National Health Investors (NHI) Tops Q3 FFO by 1c/Share; Boosts FY12 FFO Outlook
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $67.80 -2.07%
Financial Fact:
Franchise, excise and other taxes: 271K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Franchise, excise and other taxes: 271K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
National Health Investors (NYSE: NHI) reported Q3 normalized FFO of $0.80, $0.01 better than the analyst estimate of $0.79. Revenue for the quarter came in at $25.51 million versus the consensus estimate of $22.51 million.
National Health Investors sees FY2012 EPS of $3.15-3.18, versus the consensus of $3.12.
For earnings history and earnings-related data on National Health Investors (NHI) click here.
National Health Investors sees FY2012 EPS of $3.15-3.18, versus the consensus of $3.12.
For earnings history and earnings-related data on National Health Investors (NHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Nucor projects Q3 2026 earnings above prior year, below estimates
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
